$-0.12
(Market cap
$151 Mln
Revenue (TTM)
$204 Mln
P/E Ratio
--
P/B Ratio
19.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-5.2 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
26.8
-
Debt to Equity
0
-
Book Value
$0.2
-
EPS
$-0.5
-
Face value
--
-
Shares outstanding
48,200,837
10 Years Aggregate
CFO
$-61.47 Mln
EBITDA
$-153.39 Mln
Net Profit
$-195.07 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
| -7.9 | -18.9 | -31.3 | -51.0 | -4.4 | -16.7 | 9.6 |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
| -31.1 | -40.0 | 327.3 | -49.9 | -40.7 | 1,035.7 | -17.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
LifeMD (LFMD)
|
3.1 | 151.4 | 204.5 | -21.3 | -6.4 | -138.1 | -- | 19.7 |
| 61.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.6 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 57.1 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.9 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 100.8 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.5 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 321.7 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 176.3 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout LifeMD (LFMD)
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth... platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York. Read more
-
Chairman & CEO
Mr. Justin Schreiber
-
Chairman & CEO
Mr. Justin Schreiber
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for LifeMD (LFMD)
What is the current share price of LifeMD Inc (LFMD) Today?
The share price of LifeMD Inc (LFMD) is $3.14 (NASDAQ) as of 28-Aug-2026 16:00 EDT. LifeMD Inc (LFMD) has given a return of -4.37% in the last 3 years.
What is the current PB & PE ratio of LifeMD Inc (LFMD)?
Since, TTM earnings of LifeMD Inc (LFMD) is negative, P/E ratio is not available.
The P/B ratio of LifeMD Inc (LFMD) is 19.72 times as on 28-Aug-2026, a 420 premium to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-22.44 |
6.89 |
2024 |
-11.06 |
-38.09 |
2023 |
-14.78 |
86.82 |
2022 |
-1.34 |
-8.92 |
2021 |
-1.70 |
3.85 |
What is the 52 Week High and Low of LifeMD Inc (LFMD)?
The 52-week high and low of LifeMD Inc (LFMD) are Rs 7.32 and Rs 2.56 as of 31-Aug-2026.
What is the market cap of LifeMD Inc (LFMD)?
LifeMD Inc (LFMD) has a market capitalisation of $ 151 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in LifeMD Inc (LFMD)?
Before investing in LifeMD Inc (LFMD), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.